Abstract: Skins, hides and pelts are effectively degreased under mild conditions prior to tanning, in the presence of an organic primary, secondary or tertiary amine having surface-active properties and containing at least one lipophilic residue and at least one ethylene oxide unit, optionally in admixture with a non-ionic emulsifier.
Abstract: 6-Substituted-4-hydroxy-tetrahydropyran-2-ones, useful as anti-atherosclerotic agents, are obtainable by the process of the invention. The 6-substituents have a phenyl, naphthyl, tetrahydronaphthyl or indolyl nucleus bound through an ethenyl unit. The invention includes novel intermediates.
Abstract: A textile finishing process in which there is employed, as a pH regulator, a compound or a mixture of compounds of formula I ##STR1## in which p is from 1 to 20,R is hydrogen, C.sub.1-3 alkyl or C.sub.1-3 alkyl substituted by hydroxyR' has independently one of the significances given for R or is --CO--R andA is --CH.sub.2 CH.sub.2 --; --CH.sub.2 --CH.sub.2 --CH.sub.
Type:
Grant
Filed:
May 17, 1984
Date of Patent:
February 4, 1986
Assignee:
Sandoz Ltd.
Inventors:
Jose M. Palleiro Cardona, Karl-Heinz Weible
Abstract: The invention relates to a process for alkali-dry treating cellulosic fibre goods comprising the steps of(a) treating the goods with an aqueous caustic soda solution of 18.degree.-26.degree. Baume, followed by(b) drying the treated goods under tension without an intermediate rinsing or neutralization step.The aqueous caustic soda solution used in step (a) may further contain a lubricant and wetting agents.
Abstract: Compounds of formula I, ##STR1## wherein X is oxygen or sulphur, and R.sub.1 -R.sub.6 are various substituents. The compounds are useful for treating coronary insufficiency, intermittent claudication, cerebrovascular insults, spasms in muscles and hypertension.
Abstract: A 6- and/or 7-oxy-trans-1,2,3,4,4a,5,10,10a-octahydro-benzo[g]quinoline in which the 3-position is substituted by an optionally amidated carboxy group, an optionally etherified hydroxymethyl group, a cyanomethyl group, an alkyl- or aryl-thiomethyl group or a sulfamoylamino or carbamoylamino group, or a physiologically-hydrolysable and -acceptable ester thereof. The subject compounds are useful as pharmaceuticals, in particular as prolactin secretion inhibitors, dopaminergic agents ad dopamine receptor stimulating agents.
Abstract: Piperazine derivatives or pharmaceutically acceptable acid addition salts thereof are useful as neuroleptic, anti-hypertensive or bradycardic agents.
Abstract: Disclosed is a method for dyeing sueded wool- or fur-bearing skins tone-in-tone in a single bath and in one step. The dyeing is carried out with reactive dyestuffs bearing at least one reactive group selected from acryloylimino, halogenoacryloylimino and .beta.-halogenopropionylimino, in the presence of non-ionic or anionically modified polyalkoxylated surfactants.
Abstract: A precondensate obtained by reacting(A) the product of reacting a mono- or polyfunctional primary or secondary amine with cyanamide, dicyandiamide, guanidine or biguanidine and(B) an epihalohydrin is obtained in the form of a stable aqueous dispersion by acidifying the reaction product, optionally in the presence of a water-soluble polymer. The product is useful as an after-treatment agent to improve the fastness of dyeings on cotton, wool or silk.
Abstract: The invention provides a solution of one or more U.V. absorbers selected from resorcinol monobenzoate, phenyl salicylate and a benzophenone; and an emulsifier in an organic solvent system.The solutions of the invention are useful for providing level dyeings of polyester material particularly for use in the automotive industry.
Abstract: A method for the total synthesis of cyclosporins, in particular Cyclosporin A, cyclosporins produced in accordance with the method of the invention and novel intermediates, in particular novel [1S, 2R, 3R]- and [1R, 2S, 3S]-1-nitrilo-1-carbonyl-3-methyl-2-oxy-heptanes and -hept-5-enes, employed in the method of the invention.
Abstract: Process and apparatus for the production of medicament containing liposomes, comprising an aliphatic lipid-sterol-water lamellae, wherein a clear, mixed micellar medicament-detergent-aliphatic lipid-sterol sample is applied to a gel filtration column. The column effluent is continuously monitored to detect the liposome fraction eluted, which is collected. The free medicament, detergent, lipid and/or sterol may be recirculated back to the column.
Abstract: Metal-free azo compounds of the formula ##STR1## wherein Ra is an aromatic group or an active methylene coupling component radical as defined in the specification,R.sub.t is an arylazo group or a group of the formula -Y-Z,whereinY is a direct bond or a bridging radical, andZ is a basic amino or quaternary ammonium group, ##STR2## wherein each of the variables is as defined above or below, X is a direct bond or a bridging radical,x is hydrogen, hydroxy C.sub.1-4 alkyl, C.sub.1-4 alkoxy, amino or carboxy,ring B is further unsubstituted or further substituted,d is 0, 1 or 2, andn is 0 or 1,with the provisos that (i) the compounds contain an average of at least 1.3 basic water-solubilizing groups, and (ii) the compounds are free of sulfo groups,and 1:1 and 1:2 metal complexes thereof,which metal-free compounds and metal complexes are useful as dyes for leather and paper.
Type:
Grant
Filed:
August 18, 1982
Date of Patent:
October 29, 1985
Assignee:
Sandoz Ltd.
Inventors:
Paul Doswald, Emil Moriconi, Helmut Moser, Horst Schmid
Abstract: A process for the preparation of condensed triazoles of formula I ##STR1## in which R together with the triazole group form an aromatic group R.sub.1 is hydrogen or a hydrocarbon groupthe process comprisingreacting in a medium containing an organic phase a compound of formula II ##STR2## with a nitrite and an acid. The reaction is preferably carried out at a raised temperature.
Abstract: Dyeings on cellulose with direct or reactive dyestuffs are given improved wet fastness properties by aftertreatment with a reaction product or mixture of a polybasic amino compound (A) with an N-methylol compound (B) or with formaldehyde or a formaldehyde donor and optionally a crosslinking catalyst (C). Particular direct or reactive dyestuffs and polybasic amino compounds are determined to be suitable in the dyeing and aftertreatment when the dyestuff and the polybasic amino compound (A) are such that when mixed together in aqueous solution they give a precipitate which, after washing and drying does not redissolve in aqueous alkali at pH.gtoreq.12 at room temperature.
Abstract: Disclosed is a method for marking mineral tanned leather by treating the unfinished leather with an anionic aqueous dispersion of a fluorescent pigment. The marked leather can then be sorted by exposure to UV-radiation.
Abstract: A 2-methyl-8 (R) or (S) ergot peptide alkaloid in free base form or in pharmaceutically acceptable acid addition salt form is a useful anti-Parkinson agent, prolactin secretion inhibitor, anti-depressant, vigilance-increasing agent, and anti-migraine agent.
Abstract: The compound of the formula ##STR1## exists in an .alpha.-modification and a .beta.-modification, the latter being obtained by treatment of the .alpha.-form with a boiling organic solvent, each of which, but especially the .beta.-modification, is useful as a pigment for the mass pigmentation of synthetic plastics and resins, free from or containing a solvent (e.g., viscose, cellulose acetate, polyethylene, polystyrene, polyvinyl chloride, synthetic leathers and synthetic rubbers), surface coatings (e.g., oil- and water-based paints), lacquers and inks and for pigment printing, textile coating and pigmenting paper in the mass.
Abstract: This disclosure relates to the aspermatogenesis activity of(a) compounds of the formula: ##STR1## where m is an integer from 1 to 4X represents hydrogen or --OHR represents Ar, ##STR2## Ar represents ##STR3## R.sub.1 represents hydrogen, fluoro, chloro, lower alkyl or lower alkoxy, R.sub.2 and R.sub.3 each, independently, represent lower alkyl, orR.sub.2 and R.sub.3 together with N represent ##STR4## wherein n is 1, 2 or 3,R.sub.4 represents hydrogen or lower alkyl, andR.sub.5 represents hydrogen or lower alkyl, unsubstituted phenyl or phenyl mono- or di-substituted with fluoro, chloro, lower alkyl or lower alkoxy, or(b) compounds of the formula: ##STR5## where R' is Ar or ##STR6## Ar, R.sub.1, R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are as defined above, or a pharmaceutically acceptable acid addition salt thereof.